Role of first trimester screening test in predicting the
perinatal outcomes in low risk term pregnancies

Bayram, Merih; Akbarihamed, Roujin; Özdemir, Halis; Turan, Gökçe; Turgut, Ezgi; KARÇAALTINCABA, DENIZ; Konca, Sibel

doi:10.2399/prn.22.0302008

Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies

Gökçe TURAN, (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Ezgi TURGUT, (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Halis OZDEMIR, (Malatya Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Malatya, Türkiye)

Roujin AKBARİHAMED, (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Sibel KONCA, (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Deniz KARÇAALTINCABA, (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Merih BAYRAM (Gazi Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara, Türkiye)

Perinatal journal (Online)

23 1

Yıl: 2022 Cilt: 30 Sayı: 2 Sayfa Aralığı: 152 - 157 Metin Dili: İngilizce DOI: 10.2399/prn.22.0302008 İndeks Tarihi: 26-07-2022

Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies

Öz:

Objective: This study aims to investigate the relationship between the nuchal translucency (NT) values measured in the first trimester and the well-being of the newborn. Methods: The study was planned as a retrospective cross-sectional study and was conducted between January 2018 and January 2020. A total of 2394 patients who had a combined test and delivered at our university hospital were included in the study. The demographic data of the pregnant women were recorded. NT MoM values, PAPP-A and β-hCG MoM values, birth weight, gender, need for neonatal intensive care (NICU), and Apgar scores were evaluated. Results: It was found that NT (MoM) values were similar among the SGA, AGA, and LGA groups (p=0.159). PAPP-A (MoM) values were similar in the SGA group compared to AGA and LGA infant groups (p=0.947). It was also found that β-hCG (MoM) values were similar in the AGA group compared to SGA and the LGA infant groups (p=0.694). When compared with those with NICU and non-NICU, the NT, PAPP-A, β- hCG, and birth weight values were again not found to be statistically significant (p>0.05). The NT, PAPP-A, β-hCG, and male gender factors were evaluated in the Binary Logistic Regression Analysis, in which being an SGA baby was considered as a risk. It was found that a 1 mm increase in NT values increased the risk of having an SGA baby 2.63 times at a statistically significant level (OR=2.636, p=0.009, 95% CI: 1.277–5.440). PAPP-A, β-hCG levels, and having a male gender were not related to the risk of having an SGA baby. Furthermore, NT, PAPPA, β-hCG levels, and having a male gender were not associated with the risk of NICU hospitalization. Conclusion: In conclusion, we could not predict the birth weight with increased NT MoM values that were detected in the first trimester combined test in this study; however, we found that the risk of having an SGA fetus increases with a weak rise in NT value.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Nicolaides KH, Syngelaki A, Poon LC, Gil MM, Wright D. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther 2014;35:185–92. [PubMed] [CrossRef]
2. Wright D, Syngelaki A, Bradbury I, Akolekar R, Nicolaides KH. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing. Fetal Diagn Ther 2014;35: 118–26. [PubMed] [CrossRef]
3. Kagan KO, Wright D, Nicolaides KH. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cellfree DNA testing. Ultrasound Obstet Gynecol 2015;45:42–7. [PubMed] [CrossRef]
4. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-oriented two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221–6. [PubMed] [CrossRef]
5. Hendrix MLE, Bons JAP, Snellings RRG, Bekers O, Van Kuijk SMJ, Spaanderman MEA, Al-Nasiry S. Can fetal growth velocity and first trimester maternal biomarkers improve the prediction of small-for-gestational age and adverse neonatal outcome? Fetal Diagn Ther 2019;46:274–84. [PubMed] [CrossRef]
6. Kalem Z, Ellibefl Kaya A, Bak›rarar B, Naml› Kalem M. Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing? Turk J Obstet Gynecol 2019;16:35– 40. [PubMed] [CrossRef]
7. Khan J, Stafstrom M, Martines JC. Feeding of low birth weight newborns in tertiary care hospitals in Pakistan: do they follow the world health organization latest guidelines? J Coll Physicians Surg Pakistan 2015;25:583–7. [PubMed]
8. Pardo J, Peled Y, Yogev Y, Melamed N, Ben-Haroush A. Association of crown-rump length at 11 to 14 weeks’ gestation and risk of a large-for-gestational-age neonate. J Ultrasound Med 2010;29:1315–9. [PubMed] [CrossRef]
9. Kelekci S, Yilmaz B, Savan K, Sonmez S. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynaecol 2005;25:579–82. [PubMed] [CrossRef]
10. Plasencia W, González Dávila E, Tetilla V, Padrón Pérez E, García Hernández JA, González González NL. First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol 2012;39:389–95. [PubMed] [CrossRef]
11. Weissmann-Brenner A, Weisz B, Lerner-Geva L, Gindes L, Achiron R. Increased nuchal translucency is associated with large for gestational age neonates in singleton pregnancies. J Perinat Med 2011;39:305–9. [PubMed] [CrossRef]
12. Boucoiran I, Djemli A, Taillefer C, Rypens F, Delvin E, Audibert F. First-trimester prediction of birth weight. Am J Perinatol 2013;30:665–71. [PubMed] [CrossRef]
13. Timmerman E, Pajkrt E, Snijders RJM, Bilardo CM. High macrosomia rate in healthy fetuses after enlarged nuchal translucency. Prenat Diagn 2014;34:103–8. [PubMed] [CrossRef]
14. Hackmon R, Librach C, Burwick R, Rodrigues N, Farine D, Berger H. Do early fetal measurements and nuchal translucency correlate with term birth weight? J Obstet Gynaecol Canada 2017;39:750–6. [PubMed] [CrossRef]
15. Poon LCY, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH. First-trimester prediction of macrosomia. Fetal Diagn Ther 2011;29:139–47. [PubMed] [CrossRef]
16. Poon LCY, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH. Reference range of birth weight with gestation and firsttrimester prediction of small-for-gestation neonates. Prenat Diagn 2011;31:58–65. [PubMed] [CrossRef]
17. Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free betahCG and PAPP-A at 10–14 weeks of gestation. Prenat Diagn 2000;20:673–5. [PubMed] [CrossRef]
18. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al.; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191:1452–8. [PubMed] [CrossRef]
19. Kirkegaard I, Uldbjerg N, Henriksen TB. PAPP-A and free β- hCG in relation to admission to neonatal intensive care unit and neonatal disease. Prenat Diagn 2011;31:1169–75. [PubMed] [CrossRef]
20. Kharfi A, Giguère Y, De Grandpré P, Moutquin JM, Forest JC. Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnancies. Clin Biochem 2005;38:717–21. [PubMed] [CrossRef]

APA	Turan G, Turgut E, Özdemir H, Akbarihamed R, Konca S, KARÇAALTINCABA D, Bayram M (2022). Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. , 152 - 157. 10.2399/prn.22.0302008
Chicago	Turan Gökçe,Turgut Ezgi,Özdemir Halis,Akbarihamed Roujin,Konca Sibel,KARÇAALTINCABA DENIZ,Bayram Merih Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. (2022): 152 - 157. 10.2399/prn.22.0302008
MLA	Turan Gökçe,Turgut Ezgi,Özdemir Halis,Akbarihamed Roujin,Konca Sibel,KARÇAALTINCABA DENIZ,Bayram Merih Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. , 2022, ss.152 - 157. 10.2399/prn.22.0302008
AMA	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. . 2022; 152 - 157. 10.2399/prn.22.0302008
Vancouver	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. . 2022; 152 - 157. 10.2399/prn.22.0302008
IEEE	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M "Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies." , ss.152 - 157, 2022. 10.2399/prn.22.0302008
ISNAD	Turan, Gökçe vd. "Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies". (2022), 152-157. https://doi.org/10.2399/prn.22.0302008

APA	Turan G, Turgut E, Özdemir H, Akbarihamed R, Konca S, KARÇAALTINCABA D, Bayram M (2022). Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. Perinatal journal (Online), 30(2), 152 - 157. 10.2399/prn.22.0302008
Chicago	Turan Gökçe,Turgut Ezgi,Özdemir Halis,Akbarihamed Roujin,Konca Sibel,KARÇAALTINCABA DENIZ,Bayram Merih Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. Perinatal journal (Online) 30, no.2 (2022): 152 - 157. 10.2399/prn.22.0302008
MLA	Turan Gökçe,Turgut Ezgi,Özdemir Halis,Akbarihamed Roujin,Konca Sibel,KARÇAALTINCABA DENIZ,Bayram Merih Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. Perinatal journal (Online), vol.30, no.2, 2022, ss.152 - 157. 10.2399/prn.22.0302008
AMA	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. Perinatal journal (Online). 2022; 30(2): 152 - 157. 10.2399/prn.22.0302008
Vancouver	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies. Perinatal journal (Online). 2022; 30(2): 152 - 157. 10.2399/prn.22.0302008
IEEE	Turan G,Turgut E,Özdemir H,Akbarihamed R,Konca S,KARÇAALTINCABA D,Bayram M "Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies." Perinatal journal (Online), 30, ss.152 - 157, 2022. 10.2399/prn.22.0302008
ISNAD	Turan, Gökçe vd. "Role of first trimester screening test in predicting the perinatal outcomes in low risk term pregnancies". Perinatal journal (Online) 30/2 (2022), 152-157. https://doi.org/10.2399/prn.22.0302008